Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma
Zaretsky, Jesse M, Garcia-Diaz, Angel, Shin, Daniel S, Escuin-Ordinas, Helena, Hugo, Willy, Hu-Lieskovan, Siwen, Torrejon, Davis Y, Abril-Rodriguez, Gabriel, Sandoval, Salemiz, Barthly, Lucas, Saco, Justin, Homet Moreno, Blanca, Mezzadra, Riccardo, Chmielowski, Bartosz, Ruchalski, Kathleen, Shintaku, I. Peter, Sanchez, Phillip J, Puig-Saus, Cristina, Cherry, Grace, Seja, Elizabeth, Kong, Xiangju, Pang, Jia, Berent-Maoz, Beata, Comin-Anduix, Begoña, Graeber, Thomas G, Tumeh, Paul C, Schumacher, Ton N.M, Lo, Roger S, Ribas, Antoni
Published in The New England journal of medicine (01.09.2016)
Published in The New England journal of medicine (01.09.2016)
Get full text
Journal Article
Dabrafenib, trametinib and pembrolizumab or placebo in BRAF-mutant melanoma
Ascierto, Paolo Antonio, Ferrucci, Pier Francesco, Fisher, Rosalie, Del Vecchio, Michele, Atkinson, Victoria, Schmidt, Henrik, Schachter, Jacob, Queirolo, Paola, Long, Georgina V., Di Giacomo, Anna Maria, Svane, Inge Marie, Lotem, Michal, Bar-Sela, Gil, Couture, Felix, Mookerjee, Bijoyesh, Ghori, Razi, Ibrahim, Nageatte, Moreno, Blanca Homet, Ribas, Antoni
Published in Nature medicine (01.06.2019)
Published in Nature medicine (01.06.2019)
Get full text
Journal Article
Combined BRAF and MEK inhibition with PD-1 blockade immunotherapy in BRAF-mutant melanoma
Ribas, Antoni, Lawrence, Donald, Atkinson, Victoria, Agarwal, Sachin, Miller, Wilson H., Carlino, Matteo S., Fisher, Rosalie, Long, Georgina V., Hodi, F. Stephen, Tsoi, Jennifer, Grasso, Catherine S., Mookerjee, Bijoyesh, Zhao, Qing, Ghori, Razi, Moreno, Blanca Homet, Ibrahim, Nageatte, Hamid, Omid
Published in Nature medicine (01.06.2019)
Published in Nature medicine (01.06.2019)
Get full text
Journal Article
Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma
Hugo, Willy, Zaretsky, Jesse M., Sun, Lu, Song, Chunying, Moreno, Blanca Homet, Hu-Lieskovan, Siwen, Berent-Maoz, Beata, Pang, Jia, Chmielowski, Bartosz, Cherry, Grace, Seja, Elizabeth, Lomeli, Shirley, Kong, Xiangju, Kelley, Mark C., Sosman, Jeffrey A., Johnson, Douglas B., Ribas, Antoni, Lo, Roger S.
Published in Cell (24.03.2016)
Published in Cell (24.03.2016)
Get full text
Journal Article
Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression
Garcia-Diaz, Angel, Shin, Daniel Sanghoon, Moreno, Blanca Homet, Saco, Justin, Escuin-Ordinas, Helena, Rodriguez, Gabriel Abril, Zaretsky, Jesse M., Sun, Lu, Hugo, Willy, Wang, Xiaoyan, Parisi, Giulia, Saus, Cristina Puig, Torrejon, Davis Y., Graeber, Thomas G., Comin-Anduix, Begonya, Hu-Lieskovan, Siwen, Damoiseaux, Robert, Lo, Roger S., Ribas, Antoni
Published in Cell reports (Cambridge) (09.05.2017)
Published in Cell reports (Cambridge) (09.05.2017)
Get full text
Journal Article
Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma
Hugo, Willy, Zaretsky, Jesse M., Sun, Lu, Song, Chunying, Moreno, Blanca Homet, Hu-Lieskovan, Siwen, Berent-Maoz, Beata, Pang, Jia, Chmielowski, Bartosz, Cherry, Grace, Seja, Elizabeth, Lomeli, Shirley, Kong, Xiangju, Kelley, Mark C., Sosman, Jeffrey A., Johnson, Douglas B., Ribas, Antoni, Lo, Roger S.
Published in Cell (26.01.2017)
Published in Cell (26.01.2017)
Get full text
Journal Article
Pembrolizumab Plus Pegylated Interferon alfa-2b or Ipilimumab for Advanced Melanoma or Renal Cell Carcinoma: Dose-Finding Results from the Phase Ib KEYNOTE-029 Study
Atkins, Michael B, Hodi, F Stephen, Thompson, John A, McDermott, David F, Hwu, Wen-Jen, Lawrence, Donald P, Dawson, Nancy A, Wong, Deborah J, Bhatia, Shailender, James, Marihella, Jain, Lokesh, Robey, Seth, Shu, Xinxin, Homet Moreno, Blanca, Perini, Rodolfo F, Choueiri, Toni K, Ribas, Antoni
Published in Clinical cancer research (15.04.2018)
Published in Clinical cancer research (15.04.2018)
Get full text
Journal Article
Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression
Garcia-Diaz, Angel, Shin, Daniel Sanghoon, Moreno, Blanca Homet, Saco, Justin, Escuin-Ordinas, Helena, Rodriguez, Gabriel Abril, Zaretsky, Jesse M., Sun, Lu, Hugo, Willy, Wang, Xiaoyan, Parisi, Giulia, Saus, Cristina Puig, Torrejon, Davis Y., Graeber, Thomas G., Comin-Anduix, Begonya, Hu-Lieskovan, Siwen, Damoiseaux, Robert, Lo, Roger S., Ribas, Antoni
Published in Cell reports (Cambridge) (10.12.2019)
Published in Cell reports (Cambridge) (10.12.2019)
Get full text
Journal Article
Combining Targeted Therapy With Immunotherapy in BRAF-Mutant Melanoma: Promise and Challenges
HU-LIESKOVAN, Siwen, ROBERT, Lidia, MORENO, Blanca Homet, RIBAS, Antoni
Published in Journal of clinical oncology (20.07.2014)
Published in Journal of clinical oncology (20.07.2014)
Get full text
Journal Article
Three-year survival, correlates and salvage therapies in patients receiving first-line pembrolizumab for advanced Merkel cell carcinoma
Nghiem, Paul, Bhatia, Shailender, Lipson, Evan J, Sharfman, William H, Kudchadkar, Ragini R, Brohl, Andrew S, Friedlander, Philip A, Daud, Adil, Kluger, Harriet M, Reddy, Sunil A, Boulmay, Brian C, Riker, Adam, Burgess, Melissa A, Hanks, Brent A, Olencki, Thomas, Kendra, Kari, Church, Candice, Akaike, Tomoko, Ramchurren, Nirasha, Shinohara, Michi M, Salim, Bob, Taube, Janis M, Jensen, Erin, Kalabis, Mizuho, Fling, Steven P, Homet Moreno, Blanca, Sharon, Elad, Cheever, Martin A, Topalian, Suzanne L
Published in Journal for immunotherapy of cancer (01.04.2021)
Published in Journal for immunotherapy of cancer (01.04.2021)
Get full text
Journal Article
Long-Term Outcomes in KEYNOTE-052: Phase II Study Investigating First-Line Pembrolizumab in Cisplatin-Ineligible Patients With Locally Advanced or Metastatic Urothelial Cancer
Vuky, Jacqueline, Balar, Arjun V, Castellano, Daniel, O'Donnell, Peter H, Grivas, Petros, Bellmunt, Joaquim, Powles, Thomas, Bajorin, Dean, Hahn, Noah M, Savage, Mary J, Fang, Xiao, Godwin, James Luke, Frenkl, Tara L, Homet Moreno, Blanca, de Wit, Ronald, Plimack, Elizabeth R
Published in Journal of clinical oncology (10.08.2020)
Published in Journal of clinical oncology (10.08.2020)
Get full text
Journal Article
Improved antitumor activity of immunotherapy with BRAF and MEK inhibitors in BRAF(V600E) melanoma
Hu-Lieskovan, Siwen, Mok, Stephen, Homet Moreno, Blanca, Tsoi, Jennifer, Robert, Lidia, Goedert, Lucas, Pinheiro, Elaine M, Koya, Richard C, Graeber, Thomas G, Comin-Anduix, Begoña, Ribas, Antoni
Published in Science translational medicine (18.03.2015)
Published in Science translational medicine (18.03.2015)
Get more information
Journal Article
Single-cell analysis resolves the cell state transition and signaling dynamics associated with melanoma drug-induced resistance
Su, Yapeng, Wei, Wei, Robert, Lidia, Xue, Min, Tsoi, Jennifer, Garcia-Diaz, Angel, Moreno, Blanca Homet, Kim, Jungwoo, Ng, Rachel H., Lee, Jihoon W., Koya, Richard C., Comin-Anduix, Begonya, Graeber, Thomas G., Ribas, Antoni, Heath, James R.
Published in Proceedings of the National Academy of Sciences - PNAS (26.12.2017)
Published in Proceedings of the National Academy of Sciences - PNAS (26.12.2017)
Get full text
Journal Article
Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer
Powles, Thomas, Valderrama, Begoña P., Gupta, Shilpa, Bedke, Jens, Kikuchi, Eiji, Hoffman-Censits, Jean, Iyer, Gopa, Vulsteke, Christof, Park, Se Hoon, Shin, Sang Joon, Castellano, Daniel, Fornarini, Giuseppe, Li, Jian-Ri, Gümüş, Mahmut, Mar, Nataliya, Loriot, Yohann, Fléchon, Aude, Duran, Ignacio, Drakaki, Alexandra, Narayanan, Sujata, Yu, Xuesong, Gorla, Seema, Homet Moreno, Blanca, van der Heijden, Michiel S.
Published in The New England journal of medicine (07.03.2024)
Published in The New England journal of medicine (07.03.2024)
Get full text
Journal Article
Durable Tumor Regression and Overall Survival in Patients With Advanced Merkel Cell Carcinoma Receiving Pembrolizumab as First-Line Therapy
Nghiem, Paul, Bhatia, Shailender, Lipson, Evan J, Sharfman, William H, Kudchadkar, Ragini R, Brohl, Andrew S, Friedlander, Phillip A, Daud, Adil, Kluger, Harriet M, Reddy, Sunil A, Boulmay, Brian C, Riker, Adam I, Burgess, Melissa A, Hanks, Brent A, Olencki, Thomas, Margolin, Kim, Lundgren, Lisa M, Soni, Abha, Ramchurren, Nirasha, Church, Candice, Park, Song Y, Shinohara, Michi M, Salim, Bob, Taube, Janis M, Bird, Steven R, Ibrahim, Nageatte, Fling, Steven P, Homet Moreno, Blanca, Sharon, Elad, Cheever, Martin A, Topalian, Suzanne L
Published in Journal of clinical oncology (20.03.2019)
Published in Journal of clinical oncology (20.03.2019)
Get full text
Journal Article
Enfortumab Vedotin With or Without Pembrolizumab in Cisplatin-Ineligible Patients With Previously Untreated Locally Advanced or Metastatic Urothelial Cancer
O'Donnell, Peter H, Milowsky, Matthew I, Petrylak, Daniel P, Hoimes, Christopher J, Flaig, Thomas W, Mar, Nataliya, Moon, Helen H, Friedlander, Terence W, McKay, Rana R, Bilen, Mehmet A, Srinivas, Sandy, Burgess, Earle F, Ramamurthy, Chethan, George, Saby, Geynisman, Daniel M, Bracarda, Sergio, Borchiellini, Delphine, Geoffrois, Lionnel, Maroto Rey, Jose Pablo, Ferrario, Christiano, Carret, Anne-Sophie, Yu, Yao, Guseva, Maria, Homet Moreno, Blanca, Rosenberg, Jonathan E
Published in Journal of clinical oncology (01.09.2023)
Published in Journal of clinical oncology (01.09.2023)
Get full text
Journal Article
Temporal changes in treatment patterns by age group and functional status before and after PD-1/L1 inhibitor approvals in advanced urothelial carcinoma
Doshi, Gurjyot K., Li, Haojie, Burcu, Mehmet, Annavarapu, Srinivas, Wells, Karen, Imai, Kentaro, Moreno, Blanca Homet, Singhal, Puneet, Mamtani, Ronac
Published in Frontiers in oncology (02.10.2023)
Published in Frontiers in oncology (02.10.2023)
Get full text
Journal Article
Anti–PD-1 Therapy in Melanoma
Homet Moreno, Blanca, Parisi, Giulia, Robert, Lidia, Ribas, Antoni
Published in Seminars in oncology (01.06.2015)
Published in Seminars in oncology (01.06.2015)
Get full text
Journal Article